http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106544421-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106544421-B |
| titleOfInvention | Application of SPAG6 gene as ovarian tumor diagnosis and treatment marker |
| abstract | The invention relates to an application of SPAG6 gene in diagnosis and treatment of ovarian tumor. The invention proves that the SPAG6 gene has differential expression in ovarian tumor tissues and normal tissues by using QPCR and Western blot methods, detects the influence of the SPAG6 gene on the reproductive development of ovarian cancer cells SKOV-3 by using an in vitro growth curve and a paclitaxel growth inhibition test, and can be used as an index for early diagnosis of ovarian tumors by using SPAG 6. Through the experiment of SPAG6 on ovarian epidermal tumor, the invention provides a new target for diagnosis and treatment of ovarian tumor and the like, and is used for guiding the research and development of new drugs so as to improve the cure rate and survival rate of tumor patients. |
| priorityDate | 2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.